Status
Conditions
About
The primary objective of this study is to test the diagnostic sensitivity of antibody tests for the diagnosis of SARS-CoV2 infection, available to clinical laboratories, within a national network of hospitals carrying out research activities. Test the diagnostic specificity of antibody tests for the diagnosis of SARS-CoV2 infection. Complete a systematic evaluation of the different approaches. Perform Health technology Assessment (HITA) of the methodologies under study, in order to verify their reliability to the immunoglobulin levels produced by each individual exposed patient.
Enrollment
Sex
Volunteers
Inclusion criteria
All patients or individuals exposed to Sars-Cov2 Infection.
Exclusion criteria
There are no criteria for excluding patients or individuals, if not the refusal to participate to project
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal